Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Baidu Shares Rise in Hong Kong After Apollo Go Robotaxi Launch in Abu Dhabi 
Syrah Resources and Tesla Extend Deadline on Graphite Supply Dispute to March 
Trump Criticizes NYSE Texas Expansion, Calls Dallas Exchange a Blow to New York 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Pop Mart Shares Surge in Hong Kong After First Buyback in Nearly Two Years 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Renault Group Global Sales Rise 3.2% in 2025 on Strong International and EV Demand 
Micron to Buy Powerchip Fab for $1.8 Billion, Shares Surge Nearly 10% 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Valentino Garavani Dies at 93, Leaving Behind the Timeless Legacy of Valentino Red 
SALT LAKE CITY, April 26, 2017 -- LifeVantage Corporation (Nasdaq:LFVN), announced today that it will release financial results for its third quarter ended March 31, 2017, after the stock market closes on Wednesday, May 10, 2017. The Company will hold an investor conference call at 2:30 p.m. Mountain Daylight Time (4:30 p.m. Eastern Daylight Time) that same day.
Investors interested in participating in the live call can dial (888) 600-4863 from the U.S. International callers can dial (913) 312-0380. A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 17, 2017, by dialing (844) 512-2921 from the U.S. and entering confirmation code 9166571, or (412) 317-6671 from international locations, and entering confirmation code 9166571.
There also will be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for approximately 30 days.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science-based direct selling company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim® Nrf2 and NRF1 Synergizers, its line of scientifically-validated dietary supplements, the TrueScience® Anti-Aging Skin Care Regimen, Petandim™ for dogs, the AXIO® energy product line and the PhysIQ™ Smart Weight Management System. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. www.lifevantage.com
Investor Relations Contacts: Cindy England Director of Investor Relations (801) 432-9036 [email protected] -or- Scott Van Winkle Managing Director, ICR (617) 956-6736 [email protected]
